药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
3-Methylfentanyl
Abafungin
The therapeutic efficacy of Abafungin can be increased when used in combination with Tetrandrine.
3-Methylfentanyl
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Tetrandrine.
3-Methylfentanyl
Arotinolol
The risk or severity of hypotension can be increased when Arotinolol is combined with Tetrandrine.
3-Methylfentanyl
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Varicella Zoster Vaccine (Recombinant)
The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Yersinia pestis 195/p antigen (formaldehyde inactivated)
The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Pertussis vaccine
The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Smallpox (Vaccinia) Vaccine, Live
The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Tecemotide
The therapeutic efficacy of Tecemotide can be decreased when used in combination with Tetrandrine.
3-Methylfentanyl
Hepatitis B Vaccine (Recombinant)
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tetrandrine.